Opportunities for interventional radiology in paediatric oncology

Fernando M. Gómez , Allison Aguado , Alex M. Barnacle , Jurgen H. Runge , Michael Temple
{"title":"Opportunities for interventional radiology in paediatric oncology","authors":"Fernando M. Gómez ,&nbsp;Allison Aguado ,&nbsp;Alex M. Barnacle ,&nbsp;Jurgen H. Runge ,&nbsp;Michael Temple","doi":"10.1016/j.ejcped.2023.100139","DOIUrl":null,"url":null,"abstract":"<div><p>Interventional oncology (IO) has emerged as a pivotal field within interventional radiology (IR), gaining prominence in the past three decades. It has transcended its initial role in cancer care, expanding beyond biopsies and vascular access to offer a spectrum of percutaneous and transarterial procedures, transforming into a curative and palliative discipline. However, implementing IO in children presents distinctive challenges. While the technical aspects of IO procedures mirror those in adults, paediatric cases require specialised considerations. Radiologists must possess an in-depth understanding of the paediatric disease, tailor imaging modalities to the case, discern unique risks, and interpret disease markers specific to children. Notably, paediatric tumour biopsies demand significantly larger tissue samples for genetic sequencing, staging, and prognostication. Paediatric IO also confronts procedural disparities. Tumours in children may be larger relative to body size, necessitating precise radioembolisation dose calculations. The proximity of critical structures in small bodies amplifies the risk of collateral damage. When performing percutaneous ablation and endovascular therapies, these challenges must also be faced so that radiologists can navigate these complex clinical and technical considerations to ensure safe and effective interventions, all while prioritising the well-being of their young patients. This review summarises the current role and future opportunities for IO in paediatric cancer.</p></div>","PeriodicalId":94314,"journal":{"name":"EJC paediatric oncology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772610X2300137X/pdfft?md5=9500cc296b7416c07bbaacf9f6461cd5&pid=1-s2.0-S2772610X2300137X-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EJC paediatric oncology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772610X2300137X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Interventional oncology (IO) has emerged as a pivotal field within interventional radiology (IR), gaining prominence in the past three decades. It has transcended its initial role in cancer care, expanding beyond biopsies and vascular access to offer a spectrum of percutaneous and transarterial procedures, transforming into a curative and palliative discipline. However, implementing IO in children presents distinctive challenges. While the technical aspects of IO procedures mirror those in adults, paediatric cases require specialised considerations. Radiologists must possess an in-depth understanding of the paediatric disease, tailor imaging modalities to the case, discern unique risks, and interpret disease markers specific to children. Notably, paediatric tumour biopsies demand significantly larger tissue samples for genetic sequencing, staging, and prognostication. Paediatric IO also confronts procedural disparities. Tumours in children may be larger relative to body size, necessitating precise radioembolisation dose calculations. The proximity of critical structures in small bodies amplifies the risk of collateral damage. When performing percutaneous ablation and endovascular therapies, these challenges must also be faced so that radiologists can navigate these complex clinical and technical considerations to ensure safe and effective interventions, all while prioritising the well-being of their young patients. This review summarises the current role and future opportunities for IO in paediatric cancer.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
儿科肿瘤介入放射学的机遇
介入肿瘤学(IO)是介入放射学(IR)中一个举足轻重的领域,在过去三十年中逐渐崭露头角。它已经超越了最初在癌症治疗中的作用,从活检和血管通路扩展到经皮和经动脉手术,成为一门治疗和缓解疾病的学科。然而,在儿童中实施 IO 带来了独特的挑战。虽然 IO 手术的技术方面与成人相同,但儿科病例需要特别考虑。放射科医生必须对儿科疾病有深入的了解,根据病例调整成像模式,识别独特的风险,并解读儿童特有的疾病标志物。值得注意的是,儿科肿瘤活检需要更大的组织样本来进行基因测序、分期和预后判断。儿科 IO 还面临程序上的差异。儿童肿瘤相对于体型可能更大,因此需要精确计算放射性栓塞剂量。小身体的关键结构很近,这增加了附带损伤的风险。在进行经皮消融和血管内治疗时,也必须面对这些挑战,这样放射科医生才能驾驭这些复杂的临床和技术考虑因素,确保安全有效的介入治疗,同时优先考虑年幼患者的健康。本综述总结了 IO 在儿科癌症中的当前作用和未来机遇。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.20
自引率
0.00%
发文量
0
期刊最新文献
Approved medicines for paediatric solid tumours in Europe: Lessons from the life cycle of a paediatric investigation plan Common core variables for childhood cancer data integration Cross-border access to early phase clinical trials for children with cancer in the Nordic region Multimodality imaging of bone marrow involvement in paediatric oncology Cell state plasticity in neuroblastoma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1